Tacrotor 0.1% Ointment

generic_icon
Rs.734for 1 tube(s) (10 gm Ointment each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Tacrotor 0.1% w/w Ointment

Tacrolimus(0.1% w/w)

food interaction for Tacrotor Ointment

alcohol interaction for Tacrotor Ointment

pregnancy interaction for Tacrotor Ointment

lactation interaction for Tacrotor Ointment

medicine interaction for Tacrotor Ointment

food
alcohol
pregnancy
lactation
medicine
No interaction found/established
No interaction found/established
Tacrotor 0.1% Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
Tacrotor 0.1% Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED
No interaction found/established

SALT INFORMATION FOR Tacrotor 0.1% w/w Ointment

Tacrolimus(0.1% w/w)

Tacrotor ointment uses

{med_name} is used for Atopic dermatitis. It is usually used only after topical corticosteroids or emollients have not worked for you.

How tacrotor ointment works

Tacrotor 0.1% Ointment is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.

Common side effects of tacrotor ointment

Application site reactions (burning, irritation, itching and redness), Headache, Hair follicle inflammation

SUBSTITUTES FOR Tacrotor Ointment

131 Substitutes
131 Substitutes
Sorted By
RelevancePrice
  • Biomus-Forte Ointment
    (10 gm Ointment in tube)
    Rs. 32.40/gm of Ointment
    generic_icon
    Rs. 328
    save 56% more per gm of Ointment
  • Tacmate 0.1% Ointment
    (20 gm Ointment in tube)
    Rs. 25.45/gm of Ointment
    generic_icon
    Rs. 525
    save 65% more per gm of Ointment
  • Mylimus 0.1% Ointment
    (20 gm Ointment in tube)
    Rs. 36.15/gm of Ointment
    generic_icon
    Rs. 746
    save 51% more per gm of Ointment
  • Mylimus 0.1% Ointment
    (10 gm Ointment in tube)
    Rs. 30.80/gm of Ointment
    generic_icon
    Rs. 345
    save 58% more per gm of Ointment
  • Tacroz Forte Ointment
    (10 gm Ointment in tube)
    Rs. 53/gm of Ointment
    generic_icon
    Rs. 550
    save 28% more per gm of Ointment

Expert advice FOR Tacrotor Ointment

  • Tacrolimus is effective at treating eczema (atopic dermatitis) when other treatment options have failed.
  • It works by decreasing itching, redness, and skin rashes.
  • Apply thinly, to affected areas of skin only. Clean the affected area and dry well before applying Tacrolimus. Avoid contact with water after application.
  • Inform your doctor if there's no improvement even after two weeks of treatment, or if the skin gets worse.
  • Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor, as this may increase the risk of side effects.
  • Stop using Tacrolimus and consult your doctor if your eczema becomes infected.
  • Continuous long-term use of the ointment should be avoided. Use as prescribed by you doctor.

Frequently asked questions FOR Tacrotor 0.1% w/w Ointment

Tacrolimus

Q. What is Tacrotor 0.1% Ointment used for?
Tacrotor 0.1% Ointment is a medicine that modulates the immune system. It works on the immune system and mostly decreases its activity. It is used to treat moderate to severe eczema (atopic dermatitis) in adults who do not respond to steroids or develop side effects on using them. In atopic dermatitis, the skin’s immune system undergoes an overreaction and causes skin inflammation leading to itchiness, redness and dryness. Tacrotor 0.1% Ointment acts on the abnormal immune response and alters it, thereby relieving the skin inflammation and itchiness.
Q. What are the side effects of Tacrotor 0.1% Ointment?
Tacrotor 0.1% Ointment, when applied to the skin, may cause skin irritation, burning sensation and itching at the site of application. These are usually mild to moderate in severity and normally resolve within one week of starting the treatment. Redness is also a common manifestation along with sensation of warmth, pain, altered sensation and rash at the site of application. Using it increases the patients’ increased risk of getting inflamed or infected hair follicles, cold sores, acne and generalized herpes simplex infections.
Q. Is Tacrotor 0.1% Ointment ointment safe?
As compared to other immune-suppressing medicines, Tacrotor 0.1% Ointment has been found to be a safe and effective short-term treatment for atopic dermatitis. When applied on the affected part of the skin, its absorption to the blood and body is minimal. Hence, the side effects are less as compared to when taken through oral route.
Show More
Q. Does Tacrotor 0.1% Ointment has abuse potential?
No, Tacrotor 0.1% Ointment does not have abuse potential and thus, is not a controlled substance. Controlled substances have potential for abuse so they need permission by authorities and doctor for use.
Q. Does Tacrotor 0.1% Ointment cause cancer?
Long-term use of Tacrotor 0.1% Ointment has been found to have increased risk of lymph node tumors called lymphoma. Some studies have found that few patients who used Tacrotor 0.1% Ointment ointment or another similar medication developed skin cancer or lymphoma. Consult your doctor if you have to use Tacrotor 0.1% Ointment ointment for more than 6 weeks or if your eczema symptoms have not improved or are getting worse with time during your treatment.
Q. Is Tacrotor 0.1% Ointment a steroid?
No, Tacrotor 0.1% Ointment is not a steroid. It is a medicine which modulates the working of the immune system. It is used in the treatment of eczema, most commonly in atopic dermatitis. An advantage of Tacrotor 0.1% Ointment is that it does not cause skin thinning (atrophy) or other steroid-related side effects.

Content on this page was last updated on 11 November, 2024, by Dr. Varun Gupta (MD Pharmacology)